RIMA M SALIBA to Aniline Compounds
This is a "connection" page, showing publications RIMA M SALIBA has written about Aniline Compounds.
Connection Strength
0.208
-
Efficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2024 Nov; 24(11):e819-e826.
Score: 0.208